Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Oral EPI-7386 in Patients With Metastatic Castration-Resistant Prostate Cancer (EPI-7386)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04421222
Recruitment Status : Recruiting
First Posted : June 9, 2020
Last Update Posted : September 25, 2020
Sponsor:
Information provided by (Responsible Party):
ESSA Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2022
Estimated Study Completion Date : December 2022